LAVA Therapeutics NV Retained Earnings
LAVA Therapeutics NV had Retained Earnings of -$194.28 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-11-06
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$194.28M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$187.09M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$178.45M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$174.97M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-09-30 | -$194.28M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$187.09M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$178.45M 10-Q · filed 2025-05-14 |
| 2024-12-31 | -$174.97M 10-Q · filed 2025-11-06 |
| 2023-12-31 | -$149.86M 10-K · filed 2025-03-28 |